SMMRT™ Solutions for Better Outcomes
Building a Healthy World Through Microbial Biotechnology
Biofilm Management with Groundbreaking Technology
Primal Therapies' innovative technology enables its partners to pioneer new treatments for microbially-driven infections and inflammatory diseases. We offer patented functional ingredients and small molecule new drugs for biofilm, infection, and microbiome control.
With solutions that combine microbiology and molecular nutrition, our technology can impact multiple industries.
ANTIMICROBIAL RESISTANCE (AMR)
Microbial biofilms account for 80% of infections in humans. Many are now showing signs of AMR. This is impacting nosocomial infections and food-borne illnesses, to name a few. AMR results in $500 billion in economic burden every year. The World Health Organization has declared AMR one of the top 10 global public health threats facing humanity. By 2040, bacterial infections will be the world’s leading cause of death.
Novel approaches for inhibiting AMR infectious agents are in development.
DISINFECTION
In American hospitals alone, the Centers for Disease Control (CDC) estimates that Hospital Acquired Infections (HAIs) account for an estimated 1.7 million infections and 99,000 associated deaths - costing nearly $45 billion USD, annually.
For senior living residents, chronic conditions complicated by infections contributed to an annual spend of $31K per resident which puts undue financial burden on Medicare.
There is an increasing need for non-toxic and more effective disinfection agents in hospitals, schools, senior living, and beyond.
MICROBIOME MODULATION
There is growing evidence that the microbiome impacts the onset and severity of various chronic diseases. Current strategies to affect involve fecal transplant or significant antiseptic and/or antibiotic use, which can pose various risks. Interventions aimed. at modulation of bacterial composition are increasingly in the focus of research attention.
More innovative approaches to microbiome modulation are in the market and under development.
Get SMMRT™
™Selective Microbial Metabolism Regulation Technology (SMMRT)™ is a novel platform technology that develops patented small molecule agents targeting metabolic receptors and enzymes in bacteria, viruses, and fungi.
